MIDHX | MWNIX | MIDHX / MWNIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 20 years | 27 years | - |
Gain YTD | 2.988 | 3.256 | 92% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.12B | 6.12B | 100% |
Annual Yield % from dividends | 1.59 | 1.76 | 90% |
Returns for 1 year | 8.67 | 9.09 | 95% |
Returns for 3 years | -17.91 | -17.44 | 103% |
Returns for 5 years | -4.66 | -3.43 | 136% |
Returns for 10 years | 23.75 | 24.60 | 97% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
OEGAX | 30.69 | 0.02 | +0.07% |
Invesco Discovery Mid Cap Growth A | |||
NUGIX | 37.04 | -0.10 | -0.27% |
Nuveen Global Dividend Growth I | |||
LZFOX | 9.87 | -0.09 | -0.90% |
Lazard Equity Franchise Open Shares | |||
AAERX | 18.81 | -0.18 | -0.95% |
American Beacon International Eq R6 | |||
LMNOX | 43.14 | -0.42 | -0.96% |
Patient Opportunity I |